Research Article
BibTex RIS Cite

BİR BİRİNCİ BASAMAK SAĞLIK KURULUŞUNDA 30-65 YAŞ ARASI HPV TARAMASI YAPILAN KADINLARDA HPV SIKLIĞI VE KORUNMA DAVRANIŞLARI

Year 2020, Volume: 12 Issue: 1, 1 - 4, 02.03.2020
https://doi.org/10.18521/ktd.551857

Abstract

Amaç:
Her ne kadar rahim ağzı kanseri yaygın olsa da, pre-invaziv lezyonların varlığı
ve rahim ağzının kolay erişilebilir bir organ olması nedeniyle erken tanı,
önleme, tedavi ve hatta eradikasyon için uygun bir hastalıktır. Bu çalışmada bir
birinci basamak kuruluşunda yapılan HPV-DNA tarama programının sonuçlarını
değerlendirmeyi ve önlenebilir risk faktörleri için önerilerde bulunmayı
amaçladık.

Gereç
ve Yöntem:
Bu kesitsel tanımlayıcı çalışmada, bir birinci
basamak sağlık merkezinde 2014-2016 yılları arasında HPV taraması yapılan 30-65
yaş arası 716 kadının kayıtlarını değerlendirdik. Elde edilen verilerin
değerlendirilmesinde tanımlayıcı istatistiksel yöntemler ve ki kare testi
kullanıldı.

Bulgular:
Çalışmaya katılan kadınların yaş ortalaması 44,11 ± 9,25,% 97,1'i evli; İlk
cinsel ilişki yaşı en az 13 en fazla 34 idi (ortalama 19,76 ± 3,67). Kadınların%
20,81'i çeşitli miktarlarda sigara içiyor ve % 26,68'i farklı sürelerdir hormonal
kontraseptif kullanıyordu. kadınların 19'unda (% 2.65) HPV-DNA (+) bulundu.
Bunlardan 7'si (% 1) HPV-16 idi.







Sonuç:
Çalışmamızda, HPV-DNA pozitiflik oranı Türkiye'de ve yurtdışında yapılan
çalışmalardan daha düşük olsa da, yüksek riskli HPV genotip-16 oranı yüksekti. Çalışmamıza
dahil ettiğimiz kadınlarda HPV aşılaması, kondom kullanımı ve düzenli
jinekolojik muayene oranlarının yetersiz olduğu ve bunun sosyo-kültürel
faktörlerin yanı sıra ekonomik nedenlerden kaynaklanabileceği sonucuna vardık.

References

  • (1) Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424.
  • (2) Jaime Prat, Silvia Franceschi. Cancers of the female reproductive organs. In: World cancer report 2014 (ed) Bernard W. Stewart and Christopher P. Wild . International Agency for Research on Cancer, 2014; Lyon pp: 465-81
  • (3) Turgay AS, Khorshid L, Eser I. Effect of the first chemotherapy course on the quality of life cancer patients in Turkey. Cancer Nursing 2008;31:1-5.
  • (4) Xavier Castellsague´, Nubia Munoz. Cofactors in Human Papilloma virus Carcinogenesis Role of Parity, Oral Contraceptives, and Tobacco Smoking. J. Natl. Cancer Inst. Monogr. 2003; 31:20-8
  • (5) Gierisch J.M. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev.2013; 22(11):1931-43.
  • (6) Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papilloma virus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359(9312)1093-101.
  • (7) Andrae, B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nation wide audit in Sweden. J Natl Cancer Inst. 2008; 100(9): p. 622-9.
  • (8) Munoz, N., et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med. 2003; 348(6): p. 518-27
  • (9) Nuri Tasalı, Rahmi Çubuk, Ahmet Midi, et al. [Radiological Imaging in Cervical Cancer] Serviks Kanserinde Radyolojik Görüntüleme. Konuralp Tıp Dergisi 2010;2(2):33-38.
  • (10) Karaca Z M. [Cancer week 2018. The current situation in the screening programme.] Kanser haftası 2018 taramalarda güncel durum. https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/yayinlar/sunular/ulusal_kanser_haftasi_2018/Mujdegul_Karaca-2018.pdf (Accessed on: 06.02.2019)
  • (11) Ahmet Şahbaz, Onur Erol. [HPV vaccination practices] HPV aşı uygulamaları. J Turk Soc Obstet Gynecol. 2014; 2:126-30.
  • (12) Kahraman K, Göç G, Taşkın S, et.al. [Factors affecting the choice of contraceptive method: Experience of a university hospital] Kontraseptif yöntem seçimini etkileyen faktörler: Bir üniversite hastanesi deneyimi. J Turkish-German Gynecol Assoc. 2012; 13: 102-5.
  • ( 13) Erbil, N., Şenkul, A., Sağlam, Y., Ergül, N. [Determination of anxiety levels and attitudes of Turkish women before gynecologic examination] Jinekolojik muayene öncesinde Türk kadınların anksiyete seviyeleri ve muayeneye ilişkin tutumlarının belirlenmesi. Uluslararası İnsan Bilimleri Dergisi. 2008; Cilt: 5 Sayı: 1 p: 1-13.
  • (14) Tuğba Yılmaz Esencan. [Evaluation of women's attitudes and behaviors in the use of gynecological early diagnosis methods] Jinekolojik erken tanı yöntemlerinin kullanımında kadınların tutum ve davranışlarının değerlendirilmesi. Zeynep Kamil Tıp Bülteni 2009; 40 (2): 63-6.

HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center

Year 2020, Volume: 12 Issue: 1, 1 - 4, 02.03.2020
https://doi.org/10.18521/ktd.551857

Abstract

Objective
:

Although cervical cancer is common, because of the presence of pre-invasive
lesions and due to the fact that the cervix is an easily accessible organ, it
is an appropriate disease for early diagnosis, 
prevention, treatment and even eradication.



We aimed to evaluate
the results of HPV-DNA screening program in women between the ages of 30-65 in
a primary care setting and to make recommendations for preventable risk factors.



Method:
In this cross-sectional descriptive study we evaluated the records of 716 women
30-65 years old who scanned for HPV between 2014-2016 in a primary health care
center. In the evaluation of data obtained, descriptive statistical methods and
chi square test were used.



Results:
The average age of women included in the study was 44,11 ± 9,25,  97.1% were married; the age of first sexual
intercourse was minimum 13 maximum 34 (mean 19,76 ± 3,67).  Of women 20,81% smoked in various amounts,
and 26,68% of them used hormonal contraceptives for varying periods of
time.  HPV-DNA (+) was found in 19
(2.65%) of the women. Of these, 7 (1%) were HPV-16.



Conclusion:
In our study, however the positive rate of HPV-DNA is lower than the studies
done in Turkey and abroad, the high-risk HPV genotype-16 ratio was higher. We
concluded that HPV vaccination, condom use and regular gynecological
examination rates  are inadequate in
women which we included in our study and this may be due to economic reasons as
well as socio-cultural factors.

References

  • (1) Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424.
  • (2) Jaime Prat, Silvia Franceschi. Cancers of the female reproductive organs. In: World cancer report 2014 (ed) Bernard W. Stewart and Christopher P. Wild . International Agency for Research on Cancer, 2014; Lyon pp: 465-81
  • (3) Turgay AS, Khorshid L, Eser I. Effect of the first chemotherapy course on the quality of life cancer patients in Turkey. Cancer Nursing 2008;31:1-5.
  • (4) Xavier Castellsague´, Nubia Munoz. Cofactors in Human Papilloma virus Carcinogenesis Role of Parity, Oral Contraceptives, and Tobacco Smoking. J. Natl. Cancer Inst. Monogr. 2003; 31:20-8
  • (5) Gierisch J.M. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev.2013; 22(11):1931-43.
  • (6) Muñoz N, Franceschi S, Bosetti C, et al. Role of parity and human papilloma virus in cervical cancer: the IARC multicentric case-control study. Lancet 2002; 359(9312)1093-101.
  • (7) Andrae, B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nation wide audit in Sweden. J Natl Cancer Inst. 2008; 100(9): p. 622-9.
  • (8) Munoz, N., et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer. N Engl J Med. 2003; 348(6): p. 518-27
  • (9) Nuri Tasalı, Rahmi Çubuk, Ahmet Midi, et al. [Radiological Imaging in Cervical Cancer] Serviks Kanserinde Radyolojik Görüntüleme. Konuralp Tıp Dergisi 2010;2(2):33-38.
  • (10) Karaca Z M. [Cancer week 2018. The current situation in the screening programme.] Kanser haftası 2018 taramalarda güncel durum. https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/yayinlar/sunular/ulusal_kanser_haftasi_2018/Mujdegul_Karaca-2018.pdf (Accessed on: 06.02.2019)
  • (11) Ahmet Şahbaz, Onur Erol. [HPV vaccination practices] HPV aşı uygulamaları. J Turk Soc Obstet Gynecol. 2014; 2:126-30.
  • (12) Kahraman K, Göç G, Taşkın S, et.al. [Factors affecting the choice of contraceptive method: Experience of a university hospital] Kontraseptif yöntem seçimini etkileyen faktörler: Bir üniversite hastanesi deneyimi. J Turkish-German Gynecol Assoc. 2012; 13: 102-5.
  • ( 13) Erbil, N., Şenkul, A., Sağlam, Y., Ergül, N. [Determination of anxiety levels and attitudes of Turkish women before gynecologic examination] Jinekolojik muayene öncesinde Türk kadınların anksiyete seviyeleri ve muayeneye ilişkin tutumlarının belirlenmesi. Uluslararası İnsan Bilimleri Dergisi. 2008; Cilt: 5 Sayı: 1 p: 1-13.
  • (14) Tuğba Yılmaz Esencan. [Evaluation of women's attitudes and behaviors in the use of gynecological early diagnosis methods] Jinekolojik erken tanı yöntemlerinin kullanımında kadınların tutum ve davranışlarının değerlendirilmesi. Zeynep Kamil Tıp Bülteni 2009; 40 (2): 63-6.
There are 14 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Articles
Authors

Süleyman Görpelioğlu 0000-0003-4579-5970

Sümeyra Gürgen This is me 0000-0003-1887-2512

Cenk Aypak 0000-0002-8381-790X

Publication Date March 2, 2020
Acceptance Date October 7, 2019
Published in Issue Year 2020 Volume: 12 Issue: 1

Cite

APA Görpelioğlu, S., Gürgen, S., & Aypak, C. (2020). HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center. Konuralp Medical Journal, 12(1), 1-4. https://doi.org/10.18521/ktd.551857
AMA Görpelioğlu S, Gürgen S, Aypak C. HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center. Konuralp Medical Journal. March 2020;12(1):1-4. doi:10.18521/ktd.551857
Chicago Görpelioğlu, Süleyman, Sümeyra Gürgen, and Cenk Aypak. “HPV Frequency and Protection Behavior of Women With HPV Screening Between 30-65 Years in a Primary Health Care Center”. Konuralp Medical Journal 12, no. 1 (March 2020): 1-4. https://doi.org/10.18521/ktd.551857.
EndNote Görpelioğlu S, Gürgen S, Aypak C (March 1, 2020) HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center. Konuralp Medical Journal 12 1 1–4.
IEEE S. Görpelioğlu, S. Gürgen, and C. Aypak, “HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center”, Konuralp Medical Journal, vol. 12, no. 1, pp. 1–4, 2020, doi: 10.18521/ktd.551857.
ISNAD Görpelioğlu, Süleyman et al. “HPV Frequency and Protection Behavior of Women With HPV Screening Between 30-65 Years in a Primary Health Care Center”. Konuralp Medical Journal 12/1 (March 2020), 1-4. https://doi.org/10.18521/ktd.551857.
JAMA Görpelioğlu S, Gürgen S, Aypak C. HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center. Konuralp Medical Journal. 2020;12:1–4.
MLA Görpelioğlu, Süleyman et al. “HPV Frequency and Protection Behavior of Women With HPV Screening Between 30-65 Years in a Primary Health Care Center”. Konuralp Medical Journal, vol. 12, no. 1, 2020, pp. 1-4, doi:10.18521/ktd.551857.
Vancouver Görpelioğlu S, Gürgen S, Aypak C. HPV Frequency and Protection Behavior of Women with HPV Screening Between 30-65 Years in a Primary Health Care Center. Konuralp Medical Journal. 2020;12(1):1-4.